StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$370.78+2.54 (+0.69%)

Close on Nov 18, 2026Market cap $30.11BP/E 30.4Yield 0.78%

Labcorp pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Labcorp's pe ratio was 30.7× on Nov 10, 2026, against 26.4× a year earlier. Over the last 5 years it ranged from 9.6× to 45.8×, with a median of 25.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 202630.7×+6.1
2025Dec 31, 202524.6×−16.2
2024Dec 31, 202440.8×+18.4
2023Dec 29, 202322.4×+9.8
2022Dec 30, 202212.6×+1.4
2021Dec 31, 202111.2×−12.5
2020Dec 31, 202023.7×+1.4
2019Dec 31, 201922.3×+13.0
2018Dec 31, 20189.2×−13.8
2017Dec 29, 201723.0×+2.7
2016Dec 30, 201620.3×−6.7
2015Dec 31, 201527.0×+16.8
2014Dec 31, 201410.2×−4.8
2013Dec 31, 201315.1×+0.8
2012Dec 31, 201214.3×−2.9
2011Dec 30, 201117.2×+0.9
2010Dec 31, 201016.3×+1.0
2009Dec 31, 200915.4×–

More Labcorp figures

See a number that looks wrong?